Marché mondial des technologies de transfection – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché des technologies de transfection

Le marché des technologies de transfection va connaître une croissance rapide en raison de l'augmentation de l'incidence du cancer et de l'intensification de la recherche et du développement dans le domaine des thérapies cellulaires. La prévalence du cancer et le nombre de personnes obèses augmentant, la demande de transfection augmente également. Ce facteur propulse le marché des technologies de transfection. De plus, les initiatives prises par diverses organisations gouvernementales amplifient la croissance du marché.

Data Bridge Market Research analyse que le marché des technologies de transfection, qui était de 1 073,22 millions USD en 2022, devrait atteindre 2 001,22 millions USD d'ici 2030, à un TCAC de 8,1 % au cours de la période de prévision 2023 à 2030. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché des technologies de transfection  

Market Definition

Transfection technology introduces nucleic acids into cells, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA), and oligonucleotides. It is introduced through various physical, chemical, and biological methods that can aid in modifying certain cell properties. Cotransfection, electroporation, cationic lipid transfection and in-vivo transfection are all methods used. This method is commonly used in genomic studies such as gene expression, screening, RNA interference, and Vivo research, as well as the bioproduction of viruses and proteins.

Global Transfection Technologies Market Dynamics

Drivers

• Introduction of new products

Co-transfection is the introduction of more than one type of nucleic acid into a eukaryotic cell. Multiple plasmid DNAs, siRNA and plasmid DNA, and multiple miRNAs into the same cell are instances of combinations. Multiple plasmid DNA co-transfection generally aims to introduce more than one type of foreign gene into host cells. One of its applications is the creation of synthetic viral or hybrid vectors comprised of multiple plasmid DNA components. An example is the generation of a lentivirus from several plasmid vectors such as transfer, envelope, and packaging vectors in HEK293 cell line. These are some of the instances which propel the growth of market.

• Rise in transfection efficiency

Transfection efficiency can be determined by co-transfection of small RNA and plasmid DNA. This is possible by inserting a plasmid containing a luciferase reporter gene whose 3′ UTR can be recognised by a specific small RNA such as miRNA, allowing the small RNA to bind and inhibit luciferase expression. On the other hand, Co-transfection of small RNA and plasmid DNA, is required in RNA interference (RNAi) research to determine the regulatory effects of a specific small RNA, such as siRNA, on specific gene expression in a host cell.

Opportunities

• Technological advancements

Co-transfection may also involve other small molecules, such as miRNAs, which can be used to study the effects of small RNAs on targeted host cells. For instance, if the introduction of a miRNA mimic can affect the expression of a specific downstream gene in a specific cell type, the simultaneous transfection of its inhibitor sequence into the same cell is expected to reduce the post-transcriptional regulatory effect exerted by the miRNA mimics sequence alone.

Restraints/Challenges

• High cost

The cost of transfection technology instruments and home brew reagents are the major factors acting as restraints. They will further challenge the growth of the transfection technologies market during the forecast period.

This transfection technologies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transfection technologies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Transfection Technologies Market Scope

The transfection technologies market is segmented on the basis of transfection method, technology, end-user, and applications. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Virus Production
• Protein Production
• Gene Silencing
• Stem Cell Reprogramming and Differentiation
• Stable Cell Line Generation
• Therapeutic Delivery
• Bio-Medical Research
• Protein Production
• Others

Transfection Method

• Lipofection
• Eletroporation
• Nucleofection
• Cotransfection
• Cationic Lipid Transfection
• In-Vivo Transfection
• Others

Technology

• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection

End-User

• Pharmaceutical and biotechnology companies
• Contract research organizations
• Academic and research institutes

Transfection Technologies Market Regional Analysis/Insights

The transfection technologies market is analyzed and market size insights and trends are provided by country, transfection method, technology, end-user and applications as referenced above.

The countries covered in the transfection technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the transfection technologies market because of an increase in the number of cases of infectious diseases requiring antibiotics and an increase in the use of cell-based products requiring transfection methods to treat chronic diseases such as cancer, tuberculosis, and cardiovascular diseases in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to increase in the occurrences of cancer diseases in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The transfection technologies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transfection technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transfection technologies market. The data is available for historic period 2011-2021.

Competitive Landscape and Transfection Technologies Market Share Analysis

The transfection technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transfection technologies market.

Some of the major players operating in the transfection technologies market are:

• Lonza (Switzerland)
• Promega Corporation (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Roche Molecular Systems, Inc. (U.S.)
• QIAGEN (Germany)
• Inovio Pharmaceuticals (U.S.)
• Polyplus Transfection (France)
• Mirus Bio LLC (U.S.)
• Takara Bio Inc. (Japan)
• SignaGen Laboratories (U.S.)
• MaxCyte, Inc. (U.S.)
• Genlantis Inc. (U.S.)
• Techulon (U.S.)
• BioAstrum Corporation (U.S.)
• Altogen Biosystems (U.S.)
• OZ Biosciences (France)
• Boca Scientific, Inc. (U.S.)
• Biontex Laboratories GmbH (Germany)

Research Methodology: Global Transfection Technologies Market

La collecte des données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. L'analyse des parts de marché et l'analyse des tendances clés sont également les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement de l'entreprise, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et la part des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande de renseignements pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader dans la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'aux stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez pour obtenir des données dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Factbook) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

SKU-14548